Last reviewed · How we verify

NCT06567145: NECT-ITA

A Group-based Treatment for Self-stigma in People With Mental Disorders in North-east Italy

Recruiting now NA Last updated 26 November 2024
What this trial tests

NA trial testing Narrative Enhancement Cognitive Therapy (NECT) in Stigma in 416 participants. Currently enrolling.

Timeline
1 October 2024
Primary endpoint
1 October 2025
1 October 2025

Quick facts

Lead sponsorUniversita di Verona
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment416
Start date1 October 2024
Primary completion1 October 2025
Estimated completion1 October 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Universita di Verona — full company profile →

Who can join

18 and older, any sex, with Stigma or Mental Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Self-stigma refers to the internalization of negative stereotypes by individuals with mental disorders, leading to beliefs that they are dangerous, aggressive, or incapable of working. This phenomenon has harmful effects on various aspects of life, such as adherence to treatment, self-esteem, quality of life, and can increase feelings of despair and suicide risk. To address these issues, the Narrative Enhancement and Cognitive Therapy (NECT) was developed. NECT is a group-based intervention consisting of 20 sessions designed to reduce self-stigma in individuals with mental disorders. This study aims to evaluate the efficacy and feasibility of NECT in 416 patients from 26 mental health centers in Northeast Italy. It is structured as a pragmatic, multicenter, randomized controlled trial with two parallel arms. The study will assess the impact of NECT on several psychological dimensions, including levels of self-stigma, self-esteem, hope, empowerment, perception of recovery, mental well-being, and stigma-related stress. The findings of this research are expected to contribute to the understanding of effective treatments for patients with mental disorders, particularly those burdened by high levels of self-stigma, and to improve their recovery outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Assessing the effectiveness and the feasibility of a group-based treatment for self-stigma in people with mental disorders in routine mental health services in North-East Italy: study protocol for a pragmatic multisite randomized controlled trial.
    Lasalvia A, Bodini L, Cristofalo D, Fin V, et al · · 2025 · cited 1× · PMID 39891254 · DOI 10.1186/s13063-025-08739-4

Verify or expand the search:

Other recruiting trials for Stigma

Currently open trials in the same condition.

Other Universita di Verona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06567145.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing